Connect Biopharma Holdings Ltd - CNTB
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G | Ikarian Capital, LLC | 8.8% | 4,933,086 | View |
| Feb 17, 2026 | SCHEDULE 13G | Neil Shahrestani | 8.8% | 4,933,086 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Zheng Wei | 9.0% | 5,015,960 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BioFortune Inc. | 10.7% | 5,987,431 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Wubin Pan | 10.8% | 6,026,813 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | Wei Zheng | 9.9% | 5,527,528 | View |
| Nov 26, 2025 | SCHEDULE 13D/A | — | — | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.